跳至主要内容
临床试验/TCTR20210623008
TCTR20210623008已完成4 期

Efficacy of vonoprazan-based dual therapy and vonoprazan-based triple therapy for Helicobacter pylori eradication: A prospective randomized study

Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat University0 个研究点目标入组 100 人开始时间: 2021年6月23日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion criteria for patients were: patients between the ages of 18 and 70 years old diagnosed as non-ulcer dyspepsia based on the results of esophagogastroduodenoscopy (EGD) and had positive tests for H. pylori infection.

排除标准

  • The exclusion criteria included patients who previously had received H. pylori treatment therapy; who had received antibiotics, bismuth, and/or PPIs/P-CAB within the preceding 4 weeks before the enrollment, had allergy to given drug in the regimens, previously had cardiac arrhythmia including QTc prolongation, who underwent gastric surgery or who were pregnant or breastfeeding women.

研究者

发起方
Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat University

相似试验